Clinical Trial Update: Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is Known [Phase 1]

View source ↗

Summary

A Phase 1 open-dose escalation trial in pediatric patients with advanced cancers lacking standard therapy has completed, with results posted to determine the ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Neoplasms

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Leukemia, Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2018-07-30